Home › Funds › Point72 Asset Management › ANIX
Point72 Asset Management position in ANIX
ANIXA BIOSCIENCES INC · Health Care
Latest position (Q1 2026)17.28K sh
Reported value held$44.57K
Portfolio Weight0.00%
First reportedQ4 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 31.06K | $96.89K | New |
| Q1 2026 | 17.28K | $44.57K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ANIX
- Vanguard Group 1.46M sh · $4.55M · Q4 2025
- UBS Group AG 585.43K sh · $1.64M · Q2 2026
- Geode Capital Management 359.19K sh · $1.01M · Q2 2026
- Marshall Wace 328.33K sh · $919.33K · Q2 2026
- BlackRock Inc 199.75K sh · $559.31K · Q2 2026
- Northern Trust Corp 69.23K sh · $193.86K · Q2 2026
- Renaissance Technologies 59.37K sh · $166.24K · Q2 2026
- BNY Mellon 47.44K sh · $132.84K · Q2 2026
- Citadel Advisors 31.89K sh · $89.28K · Q2 2026
- CPP Investments 13.50K sh · $37.80K · Q2 2026
- Charles Schwab Investment Management 12.80K sh · $35.83K · Q2 2026
- Wells Fargo & Co 12.00K sh · $33.60K · Q2 2026